GemVax Raises 52.1 Billion KRW Through Capital Increase and Convertible Bonds
On December 24, GemVax, a KOSDAQ-listed company, announced that it has decided to raise approximately 17 billion KRW in operating funds, including research and development expenses, through a third-party allotment capital increase. The recipients are Gem&Company, the largest shareholder, and Kim Kiho, CEO of GemVax.
On the same day, GemVax also announced that it would raise 35.1 billion KRW in operating funds, including research and development expenses, through the issuance of convertible bonds (CB). The maturity date for the bonds is January 23, 2029.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
As a result, GemVax will have raised a total of 52.1 billion KRW in funds.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.